DocDollars

Omnilife Science, Inc

MA · United States · Reporting entity ID 100000010553

Total reported 2019–2025
$11.9M
#444 of 2,960 reporting companies — 0% of all reported industry payments
$8.83M in general payments across 4,737 records, plus $630K in research funding across 184 records.

How it breaks down

General payments $8,834,585
Research funding $629,704
Ownership & investment $2,422,406

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Omnilife Science, Inc reported $11.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #444 of 2,960 reporting companies. 5% of that was research funding and 95% general payments such as consulting, speaking, food and travel. 4,737 general payment records and 184 research records were filed.

Common questions about Omnilife Science, Inc

How much has Omnilife Science, Inc paid US doctors?

Omnilife Science, Inc reported $11,886,695 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $8,834,585 in general payments, $629,704 in research funding and $2,422,406 in ownership and investment interests.

How does Omnilife Science, Inc rank among drug and device companies?

It ranks #444 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Omnilife Science, Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.